• Guru, F. R., Akhter, R., Bashir, S., Nisar, S. A., Mir, M. H., Zahir, Z., ... & Ara, U. (2024). Efficacy and Safety Profile of Biosimilar Polyethylene Glycol (PEG)-Asparaginase (Asviia) in Patients With Acute Leukemia: A Retrospective Study From Kashmir. Cureus, 16(11).
• Heo, Y. A., Syed, Y. Y., & Keam, S. J. (2019). Pegaspargase: a review in acute lymphoblastic leukaemia. Drugs, 79(7), 767-777.
• Graham, M. L. (2003). Pegaspargase: a review of clinical studies. Advanced drug delivery reviews, 55(10), 1293-1302.
• Ettinger, A. R. (1995). Pegaspargase (oncaspar). Journal of Pediatric Oncology Nursing, 12(1), 46-48.
• Holle, L. M. (1997). Pegaspargase: an alternative?. Annals of Pharmacotherapy, 31(5), 616-624.